Literature DB >> 1857378

Purification and characterization of a membrane-bound acid phosphatase of Leishmania mexicana.

B Menz1, G Winter, T Ilg, F Lottspeich, P Overath.   

Abstract

As defined by the reaction with monoclonal antibodies, Leishmania mexicana promastigotes contain two acid phosphatases which together comprise about 90% of the cellular activity. A first enzyme recognized by monoclonal antibody AP4 is largely membrane-bound. The protein has an apparent molecular weight of 70,000-72,000, carries about seven N-linked glycan chains and is present in approximately 16,000 copies per cell. The protein is also expressed in the amastigote stage. A second enzyme reactive with monoclonal antibody AP3, that also recognizes lipophosphoglycan and a secreted acid phosphatase, is mainly found in the soluble fraction of promastigote lysates. It is suggested that this enzyme is the precursor of the secreted protein. The N-terminal sequences of the phosphatase recognized by AP4 and the secreted enzyme are similar but not identical. AP4 does not cross-react with phosphatase activity of Leishmania major or Leishmania donovani promastigotes, while AP3 recognizes part of the cellular and all of the secreted phosphatase activity of L. donovani promastigotes but not that of L. major which does not release an acid phosphatase into the culture medium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1857378     DOI: 10.1016/0166-6851(91)90152-v

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  22 in total

1.  Proteophosphoglycans of Leishmania mexicana. Molecular cloning and characterization of the Leishmania mexicana ppg2 gene encoding the proteophosphoglycans aPPG and pPPG2 that are secreted by amastigotes and promastigotes.

Authors:  U Göpfert; N Goehring; C Klein; T Ilg
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

2.  Protein kinase involved in flagellar-length control.

Authors:  Martin Wiese; Daniela Kuhn; Christoph G Grünfelder
Journal:  Eukaryot Cell       Date:  2003-08

3.  Modulation of Leishmania major aquaglyceroporin activity by a mitogen-activated protein kinase.

Authors:  Goutam Mandal; Mansi Sharma; Martin Kruse; Claudia Sander-Juelch; Laura A Munro; Yong Wang; Jenny Veide Vilg; Markus J Tamás; Hiranmoy Bhattacharjee; Martin Wiese; Rita Mukhopadhyay
Journal:  Mol Microbiol       Date:  2012-07-26       Impact factor: 3.501

4.  Cryptosporidium parvum: identification and characterization of an acid phosphatase.

Authors:  María Magdalena Aguirre-García; Pablo C Okhuysen
Journal:  Parasitol Res       Date:  2007-01-25       Impact factor: 2.289

Review 5.  The genetics of Leishmania virulence.

Authors:  Eugenia Bifeld; Joachim Clos
Journal:  Med Microbiol Immunol       Date:  2015-06-06       Impact factor: 3.402

Review 6.  Ecto-phosphatases in protozoan parasites: possible roles in nutrition, growth and ROS sensing.

Authors:  Daniela Cosentino-Gomes; José Roberto Meyer-Fernandes
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

7.  A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host.

Authors:  M Wiese
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

8.  Glycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate-mannose synthase gene deletion mutants.

Authors:  A Garami; A Mehlert; T Ilg
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

9.  Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability.

Authors:  A Garami; T Ilg
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

10.  Secreted acid phosphatase of Leishmania mexicana: a filamentous phosphoglycoprotein polymer.

Authors:  T Ilg; Y D Stierhof; R Etges; M Adrian; D Harbecke; P Overath
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.